News
Stay up to date on our latest investments and exciting developments, backing the next generation of founders from the Ruhr region and beyond.
First Closing of €31M of Gründerfonds Ruhr II
Essen, 07 October 2024 - Gründerfonds Ruhr ("GFR") is kicking off its second fund generation with the first closing of Gründerfonds Ruhr II with an initial fund volume of €31M. The fund is offering financial and strategic support to startups from the Ruhr region and...
Maurice Reinhard joins as Investment Associate
Essen, 01 September 2024 – Maurice Reinhard has joined Gründerfonds Ruhr (Ruhrgründer Management GmbH) as an Investment Associate, adding to the team as it prepares for the launch of the second generation of Gründerfonds Ruhr. Startup expertise from the Ruhr region...
Ann-Christin Kortenbrede joins Gründerfonds Ruhr as Managing Partner
Essen, 01 March 2024 - Ann-Christin Kortenbrede is joining Gründerfonds Ruhr (Ruhrgründer Management GmbH) as the second Managing Partner alongside Jan Gräfe. The two build the new management team of the new fund generation that will be launched in 2024. From the...
talpasolutions raises €15M Series B
Essen, 28 March 2024 - talpasolutions, a leading IIoT (Industrial Internet of Things), analytics and intelligence solution provider for heavy industry, is announcing today it has raised €15 million in Series B funding led by Bosch Ventures and MIG Capital. The round...
Gründerfonds Ruhr invests in VMRay
Bochum, 19 December 2022 - VMRay, a globally successful provider of solutions for detecting and analysing advanced malware and phishing threats, announces the extension of its Series B funding round. The expansion round was led by global alternative asset alternative...
Gründerfonds Ruhr invests in Spherity
Essen, 22 March 2022 - Spherity is proud to announce that Gründerfonds Ruhr has joined our latest investment round alongside our existing investors, High Tech Gründerfonds and SeedCapital Dortmund. With Gründerfonds Ruhr as a trusted partner, we...
Emergence Therapeutics raises oversubscribed €87M Series A Financing
Duisburg, 7 December 2021 - Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, today announces that it has closed an €87 million series A financing round. The round...
Abalos completes €43M Series A extension
Düsseldorf, 14 October 2021 - Abalos Therapeutics today announced an expansion of its Series A financing. This increases the company's financing volume of the round to €43M ($50M). The expansion round was led by Seventure Partners, with support from Coparion, Ventura...
Jan Gräfe joins Gründerfonds Ruhr as Managing Director
4.5 Million Euro Series A Financing for talpasolutions
NRW.BANK Joins Venture Fund.
Emergence Therapeutics announces a bumped-up Follow-on Seed Round Financing
Duisburg, Marseille, 25 November 2020 - Emergence Therapeutics AG, a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers, announces that is has closed a Bumped-up Follow-on Seed Round...
NRW.BANK grants convertible loan to Masterplan.com
Single-digit Million Financing for Online Training Platform.
VISUS Industry receives financing to lead digital material testing revolution
Start-up from Bochum digitizes and archives test processes.
Pitch your startup.
Shape the future.
Ready to scale your idea into success? Submit your pitch deck and get in touch with us. We're seeking startups with a disruptive vision that have the power to shape the future.